A phase Ib/IIa trial to evaluate the CCK2 receptor antagonist Z-360 in combination with gemcitabine in patients with advanced pancreatic cancer

T Meyer; ME Caplin; Daniel Palmer; JW Valle; M Larvin; JS Waters; F Coxon; I Borbath; M Peeters; E Nagano

doi:10.1016/j.ejca.2009.11.004

A phase Ib/IIa trial to evaluate the CCK2 receptor antagonist Z-360 in combination with gemcitabine in patients with advanced pancreatic cancer

T Meyer
, ME Caplin
, Daniel Palmer
, JW Valle
, M Larvin
, JS Waters
, F Coxon
, I Borbath
, M Peeters
, E Nagano

Cancer and Genomic Sciences

Research output: Contribution to journal › Article

26 Citations (Scopus)

Original language	English
Pages (from-to)	526-533
Number of pages	8
Journal	European Journal of Cancer
Volume	46
Issue number	3
DOIs	https://doi.org/10.1016/j.ejca.2009.11.004
Publication status	Published - 1 Feb 2010

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Access to Document

10.1016/j.ejca.2009.11.004

Cite this

@article{745bec02a83d4d718345d02ba8d4d39d,

title = "A phase Ib/IIa trial to evaluate the CCK2 receptor antagonist Z-360 in combination with gemcitabine in patients with advanced pancreatic cancer",

author = "T Meyer and ME Caplin and Daniel Palmer and JW Valle and M Larvin and JS Waters and F Coxon and I Borbath and M Peeters and E Nagano",

year = "2010",

month = feb,

day = "1",

doi = "10.1016/j.ejca.2009.11.004",

language = "English",

volume = "46",

pages = "526--533",

journal = "European Journal of Cancer",

issn = "1879-0852",

publisher = "Elsevier",

number = "3",

}

TY - JOUR

T1 - A phase Ib/IIa trial to evaluate the CCK2 receptor antagonist Z-360 in combination with gemcitabine in patients with advanced pancreatic cancer

AU - Meyer, T

AU - Caplin, ME

AU - Palmer, Daniel

AU - Valle, JW

AU - Larvin, M

AU - Waters, JS

AU - Coxon, F

AU - Borbath, I

AU - Peeters, M

AU - Nagano, E

PY - 2010/2/1

Y1 - 2010/2/1

U2 - 10.1016/j.ejca.2009.11.004

DO - 10.1016/j.ejca.2009.11.004

M3 - Article

C2 - 20006921

SN - 1879-0852

SN - 1879-2995

VL - 46

SP - 526

EP - 533

JO - European Journal of Cancer

JF - European Journal of Cancer

IS - 3

ER -